Neuroendocrine tumors, kidney, liver, pancreatic, medullary thyroid cancer, prostate and breast cancer
Ipsen’s commitment to oncology is demonstrated by its growing portfolio of therapies aimed at improving the lives of people living with cancer.Read more
Neurodegenerative, rare neuroinflammatory and movement disorders
With over 25 years of research, development and commercial experience in neuroscience, we are fully committed to improving health outcomes for patients suffering from debilitating neurological disorders.Read more
Bone disorders, growth disorders, rare cancers and rare neurogenetic disorders
Working with the rare disease community, we strive to better understand the challenges faced by those living with rare diseases and their families, and then use our expertise to help address them.Read more
At Ipsen, our research decisions are guided by patient outcomes.
Emphasizing a culture of open innovation, we focus our R&D efforts on accelerating prioritized internal projects while actively sourcing external assets.Read more